Description

The Hepatic Fibrosis Test YRA317 // YRA321 is an essential tool for early detection and treatment of liver fibrosis, which can significantly enhance a patient’s quality of life. Accurate and timely diagnosis is crucial as early hepatic fibrosis is reversible, whereas cirrhosis is more challenging to treat. Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, this test offers reliable results using advanced technology.

Market Price

The cost of hepatic fibrosis tests can vary depending on the supplier and region. Typically, the market price for such tests ranges from $300 to $500, making it an affordable and worthwhile investment for healthcare facilities aiming to provide comprehensive liver health assessments.

Frequently Asked Questions

What parameters does the Hepatic Fibrosis Test YRA317 // YRA321 measure? This test measures several key indicators of liver fibrosis including PIIINP, CIV, LN, HA, and CG.

Is the test compatible with other analyzers? Yes, it is compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390.

What are the storage requirements? The test should be stored between 2-8°C to maintain its efficacy.

Advantages and Disadvantages

The main advantage of the Hepatic Fibrosis Test YRA317 // YRA321 is its ability to provide early detection of liver fibrosis, which is crucial for effective treatment. It also offers high compatibility with existing analyzers and predicts long-term prognosis improvement. A potential downside is the requirement for refrigeration, which may not be suitable for all facilities.

Use in the Field

In clinical settings, the Hepatic Fibrosis Test YRA317 // YRA321 is employed to monitor patients with risk factors for liver disease. Hospitals and clinics utilize this test to make informed decisions about treatment plans and to track the progression or regression of fibrosis over time.

Recommendations

To ensure optimal results, it is recommended to follow the storage guidelines faithfully and perform regular calibrations using 2/6 point calibrations for accuracy. Regularly train staff on the use of compatible analyzers and interpretation of test results to maximize the test’s potential benefits. For those interested in acquiring this test, we invite you to request a quote or generate an automatic quote through Kalstein Plus to experience its benefits firsthand.

Features

– Early detection of liver fibrosis for proactive treatment

– Compatibility with CLIA analysis mode

– Robust range of tested parameters including PIIINP and CIV

– Convenient packaging options with long shelf life

Technical Specifications